

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | viral transcription (GO:0019083) | 8.19622107 |
| 2 | ribosomal small subunit biogenesis (GO:0042274) | 7.91044790 |
| 3 | translational termination (GO:0006415) | 7.88344809 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 7.09070223 |
| 5 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 6.89438219 |
| 6 | cotranslational protein targeting to membrane (GO:0006613) | 6.83843072 |
| 7 | protein targeting to ER (GO:0045047) | 6.79226200 |
| 8 | translational elongation (GO:0006414) | 6.60503705 |
| 9 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 6.46843477 |
| 10 | protein localization to endoplasmic reticulum (GO:0070972) | 6.40470081 |
| 11 | ribosomal large subunit biogenesis (GO:0042273) | 6.22724955 |
| 12 | cellular protein complex disassembly (GO:0043624) | 6.21710855 |
| 13 | viral life cycle (GO:0019058) | 6.18338461 |
| 14 | maturation of SSU-rRNA (GO:0030490) | 6.17877714 |
| 15 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.99856664 |
| 16 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.84178744 |
| 17 | translational initiation (GO:0006413) | 5.77114376 |
| 18 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.73805514 |
| 19 | ATP synthesis coupled proton transport (GO:0015986) | 5.73805514 |
| 20 | protein complex disassembly (GO:0043241) | 5.27826659 |
| 21 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.14616171 |
| 22 | macromolecular complex disassembly (GO:0032984) | 5.03247281 |
| 23 | translation (GO:0006412) | 4.97651727 |
| 24 | proteasome assembly (GO:0043248) | 4.90060608 |
| 25 | DNA deamination (GO:0045006) | 4.88055957 |
| 26 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.83413852 |
| 27 | termination of RNA polymerase III transcription (GO:0006386) | 4.83413852 |
| 28 | respiratory electron transport chain (GO:0022904) | 4.66645081 |
| 29 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.59492812 |
| 30 | protein neddylation (GO:0045116) | 4.54865326 |
| 31 | electron transport chain (GO:0022900) | 4.54337185 |
| 32 | protein targeting to membrane (GO:0006612) | 4.43938405 |
| 33 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.29508687 |
| 34 | GTP biosynthetic process (GO:0006183) | 4.28978196 |
| 35 | chaperone-mediated protein transport (GO:0072321) | 4.18069184 |
| 36 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 4.16086008 |
| 37 | cellular component biogenesis (GO:0044085) | 4.08754947 |
| 38 | mRNA catabolic process (GO:0006402) | 3.96377974 |
| 39 | protein complex biogenesis (GO:0070271) | 3.95420078 |
| 40 | regulation of mitochondrial translation (GO:0070129) | 3.92536925 |
| 41 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.90893020 |
| 42 | rRNA processing (GO:0006364) | 3.88121264 |
| 43 | UTP biosynthetic process (GO:0006228) | 3.87853798 |
| 44 | 7-methylguanosine mRNA capping (GO:0006370) | 3.76869216 |
| 45 | rRNA metabolic process (GO:0016072) | 3.73942807 |
| 46 | 7-methylguanosine RNA capping (GO:0009452) | 3.71941609 |
| 47 | RNA capping (GO:0036260) | 3.71941609 |
| 48 | cullin deneddylation (GO:0010388) | 3.70843292 |
| 49 | protein deneddylation (GO:0000338) | 3.70790217 |
| 50 | spliceosomal snRNP assembly (GO:0000387) | 3.69674204 |
| 51 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.69101642 |
| 52 | spliceosomal complex assembly (GO:0000245) | 3.68438061 |
| 53 | RNA catabolic process (GO:0006401) | 3.68061984 |
| 54 | NADH dehydrogenase complex assembly (GO:0010257) | 3.60525458 |
| 55 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.60525458 |
| 56 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.60525458 |
| 57 | rRNA methylation (GO:0031167) | 3.57130305 |
| 58 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.54820150 |
| 59 | protein targeting to mitochondrion (GO:0006626) | 3.52465830 |
| 60 | establishment of integrated proviral latency (GO:0075713) | 3.52449852 |
| 61 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.50793965 |
| 62 | establishment of protein localization to mitochondrion (GO:0072655) | 3.47491027 |
| 63 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.38164953 |
| 64 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.35176121 |
| 65 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.34629138 |
| 66 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.34410887 |
| 67 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.34410887 |
| 68 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.32434531 |
| 69 | protein-cofactor linkage (GO:0018065) | 3.31741491 |
| 70 | pseudouridine synthesis (GO:0001522) | 3.31393757 |
| 71 | negative regulation of ligase activity (GO:0051352) | 3.31201821 |
| 72 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.31201821 |
| 73 | transcription from RNA polymerase I promoter (GO:0006360) | 3.28612251 |
| 74 | DNA damage response, detection of DNA damage (GO:0042769) | 3.23548921 |
| 75 | positive regulation of ligase activity (GO:0051351) | 3.21555245 |
| 76 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.21406326 |
| 77 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.21277984 |
| 78 | UTP metabolic process (GO:0046051) | 3.20621758 |
| 79 | base-excision repair, AP site formation (GO:0006285) | 3.20360337 |
| 80 | maturation of 5.8S rRNA (GO:0000460) | 3.19863229 |
| 81 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.19556173 |
| 82 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.18982975 |
| 83 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.18080962 |
| 84 | tRNA processing (GO:0008033) | 3.17767938 |
| 85 | establishment of protein localization to membrane (GO:0090150) | 3.16389304 |
| 86 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.15878391 |
| 87 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.15208255 |
| 88 | protein localization to mitochondrion (GO:0070585) | 3.15128825 |
| 89 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.14976462 |
| 90 | CTP biosynthetic process (GO:0006241) | 3.14910744 |
| 91 | CTP metabolic process (GO:0046036) | 3.14910744 |
| 92 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.13146299 |
| 93 | rRNA modification (GO:0000154) | 3.12560784 |
| 94 | transcription from mitochondrial promoter (GO:0006390) | 3.12329801 |
| 95 | establishment of viral latency (GO:0019043) | 3.11834937 |
| 96 | protein targeting (GO:0006605) | 3.10704065 |
| 97 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.10380277 |
| 98 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.10380277 |
| 99 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.10346899 |
| 100 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.09944030 |
| 101 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.09944030 |
| 102 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.09944030 |
| 103 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.09891598 |
| 104 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.08902705 |
| 105 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.08902705 |
| 106 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.07526803 |
| 107 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.05604480 |
| 108 | mitochondrial transport (GO:0006839) | 3.05264363 |
| 109 | hydrogen ion transmembrane transport (GO:1902600) | 3.05121993 |
| 110 | termination of RNA polymerase I transcription (GO:0006363) | 3.04865914 |
| 111 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.04436546 |
| 112 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.03712326 |
| 113 | ATP biosynthetic process (GO:0006754) | 3.03136723 |
| 114 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.02281519 |
| 115 | DNA replication checkpoint (GO:0000076) | 3.01682236 |
| 116 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.96278906 |
| 117 | ribosome biogenesis (GO:0042254) | 2.95477640 |
| 118 | formation of translation preinitiation complex (GO:0001731) | 2.95327420 |
| 119 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.95150569 |
| 120 | peptidyl-histidine modification (GO:0018202) | 2.94694974 |
| 121 | establishment of protein localization to organelle (GO:0072594) | 2.94272750 |
| 122 | ncRNA processing (GO:0034470) | 2.93493710 |
| 123 | cytochrome complex assembly (GO:0017004) | 2.93125868 |
| 124 | inner mitochondrial membrane organization (GO:0007007) | 2.92394557 |
| 125 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.92357349 |
| 126 | respiratory chain complex IV assembly (GO:0008535) | 2.92226864 |
| 127 | regulation of cellular amine metabolic process (GO:0033238) | 2.86081092 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.38924060 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.51167156 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.51011732 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.31027407 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.05102155 |
| 6 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.83668200 |
| 7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.82022181 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.80850492 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.51967124 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.50053607 |
| 11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.46486059 |
| 12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.37437097 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.37303432 |
| 14 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.23185451 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.16156436 |
| 16 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.15152356 |
| 17 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 3.14473913 |
| 18 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.06990102 |
| 19 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.77555716 |
| 20 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.68249820 |
| 21 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.64284225 |
| 22 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.46256230 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.39262450 |
| 24 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.29392152 |
| 25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.22314157 |
| 26 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.20894654 |
| 27 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.18367273 |
| 28 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.17694960 |
| 29 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.09705076 |
| 30 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.09640133 |
| 31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.05086103 |
| 32 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.97434930 |
| 33 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.96620663 |
| 34 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.89156846 |
| 35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.87636031 |
| 36 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.81085293 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.75757907 |
| 38 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.74110752 |
| 39 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.71267091 |
| 40 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.69122332 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64608923 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62605579 |
| 43 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.60704798 |
| 44 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.58948061 |
| 45 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.57359120 |
| 46 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.56639758 |
| 47 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.53631913 |
| 48 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.52748198 |
| 49 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.50273566 |
| 50 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.47081931 |
| 51 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.44626848 |
| 52 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.41802796 |
| 53 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.38036884 |
| 54 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.37663019 |
| 55 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.36748161 |
| 56 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.34397460 |
| 57 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.27513824 |
| 58 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27001430 |
| 59 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25579565 |
| 60 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.21207555 |
| 61 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.18616765 |
| 62 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.15863119 |
| 63 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.15863119 |
| 64 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.15863119 |
| 65 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.14036973 |
| 66 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.10919971 |
| 67 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.10731791 |
| 68 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.08810194 |
| 69 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.05437814 |
| 70 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05329840 |
| 71 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.00957741 |
| 72 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.00038911 |
| 73 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.99929375 |
| 74 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98458526 |
| 75 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.97299110 |
| 76 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.96751269 |
| 77 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.96675902 |
| 78 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.96418115 |
| 79 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.94976367 |
| 80 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.94752146 |
| 81 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.94669434 |
| 82 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.93253395 |
| 83 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91325440 |
| 84 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.90520798 |
| 85 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.89499043 |
| 86 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.89322268 |
| 87 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.86977992 |
| 88 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.86146033 |
| 89 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.85592838 |
| 90 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.85474348 |
| 91 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.85043654 |
| 92 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.84196570 |
| 93 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.83377027 |
| 94 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.83231015 |
| 95 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.82864760 |
| 96 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.82463436 |
| 97 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.82257031 |
| 98 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80238624 |
| 99 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.79217354 |
| 100 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.79001262 |
| 101 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.78265797 |
| 102 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.76330492 |
| 103 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.76043270 |
| 104 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.75264695 |
| 105 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.72622663 |
| 106 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.72234819 |
| 107 | VDR_22108803_ChIP-Seq_LS180_Human | 0.71967054 |
| 108 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.71675602 |
| 109 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.71648483 |
| 110 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.70756834 |
| 111 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.69542322 |
| 112 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.68580014 |
| 113 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.67563197 |
| 114 | AR_20517297_ChIP-Seq_VCAP_Human | 0.66458748 |
| 115 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.64797195 |
| 116 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.64686467 |
| 117 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.64643508 |
| 118 | GATA3_26560356_Chip-Seq_TH2_Human | 0.64170641 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 6.53696347 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.78198780 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.68458495 |
| 4 | MP0003136_yellow_coat_color | 3.66840994 |
| 5 | MP0004957_abnormal_blastocyst_morpholog | 2.66529221 |
| 6 | MP0008932_abnormal_embryonic_tissue | 2.62871456 |
| 7 | MP0009697_abnormal_copulation | 2.53661472 |
| 8 | MP0001529_abnormal_vocalization | 2.39179265 |
| 9 | MP0004381_abnormal_hair_follicle | 2.27037560 |
| 10 | MP0002132_abnormal_respiratory_system | 2.17602811 |
| 11 | MP0001986_abnormal_taste_sensitivity | 2.10967780 |
| 12 | MP0003718_maternal_effect | 2.08906425 |
| 13 | MP0002277_abnormal_respiratory_mucosa | 2.05041553 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.03875797 |
| 15 | MP0001905_abnormal_dopamine_level | 2.03310191 |
| 16 | MP0008058_abnormal_DNA_repair | 2.02951297 |
| 17 | MP0003111_abnormal_nucleus_morphology | 2.01739669 |
| 18 | MP0003077_abnormal_cell_cycle | 1.97726718 |
| 19 | MP0003315_abnormal_perineum_morphology | 1.95583584 |
| 20 | MP0008057_abnormal_DNA_replication | 1.95172450 |
| 21 | MP0005084_abnormal_gallbladder_morpholo | 1.93204050 |
| 22 | MP0010094_abnormal_chromosome_stability | 1.91380033 |
| 23 | MP0006292_abnormal_olfactory_placode | 1.90194186 |
| 24 | MP0002163_abnormal_gland_morphology | 1.89023077 |
| 25 | MP0002102_abnormal_ear_morphology | 1.87381612 |
| 26 | MP0001188_hyperpigmentation | 1.80163676 |
| 27 | MP0001764_abnormal_homeostasis | 1.80110585 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.76863278 |
| 29 | MP0001873_stomach_inflammation | 1.76389367 |
| 30 | MP0003186_abnormal_redox_activity | 1.71764544 |
| 31 | MP0008875_abnormal_xenobiotic_pharmacok | 1.69743508 |
| 32 | MP0003786_premature_aging | 1.69149787 |
| 33 | MP0000372_irregular_coat_pigmentation | 1.67102077 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.65429207 |
| 35 | MP0005409_darkened_coat_color | 1.62265050 |
| 36 | MP0004142_abnormal_muscle_tone | 1.61072426 |
| 37 | MP0008872_abnormal_physiological_respon | 1.55471632 |
| 38 | MP0005174_abnormal_tail_pigmentation | 1.49602302 |
| 39 | MP0002751_abnormal_autonomic_nervous | 1.49281584 |
| 40 | MP0002736_abnormal_nociception_after | 1.45613869 |
| 41 | MP0002638_abnormal_pupillary_reflex | 1.42714749 |
| 42 | MP0003941_abnormal_skin_development | 1.40780304 |
| 43 | MP0002938_white_spotting | 1.40431072 |
| 44 | MP0006276_abnormal_autonomic_nervous | 1.37040651 |
| 45 | MP0004147_increased_porphyrin_level | 1.36789291 |
| 46 | MP0004133_heterotaxia | 1.31945060 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.29253078 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.26660372 |
| 49 | MP0005332_abnormal_amino_acid | 1.25561137 |
| 50 | MP0000490_abnormal_crypts_of | 1.24562479 |
| 51 | MP0006036_abnormal_mitochondrial_physio | 1.24105531 |
| 52 | MP0003880_abnormal_central_pattern | 1.22074595 |
| 53 | MP0008007_abnormal_cellular_replicative | 1.21245068 |
| 54 | MP0003938_abnormal_ear_development | 1.20456474 |
| 55 | MP0003646_muscle_fatigue | 1.19758721 |
| 56 | MP0009785_altered_susceptibility_to | 1.19614078 |
| 57 | MP0003011_delayed_dark_adaptation | 1.19133420 |
| 58 | MP0005075_abnormal_melanosome_morpholog | 1.15380606 |
| 59 | MP0003195_calcinosis | 1.14482919 |
| 60 | MP0003724_increased_susceptibility_to | 1.12269442 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.12032805 |
| 62 | MP0006035_abnormal_mitochondrial_morpho | 1.11945218 |
| 63 | MP0008873_increased_physiological_sensi | 1.10425562 |
| 64 | MP0005636_abnormal_mineral_homeostasis | 1.09407025 |
| 65 | MP0005408_hypopigmentation | 1.07673751 |
| 66 | MP0005000_abnormal_immune_tolerance | 1.06695047 |
| 67 | MP0005410_abnormal_fertilization | 1.06682032 |
| 68 | MP0001968_abnormal_touch/_nociception | 1.06413977 |
| 69 | MP0005671_abnormal_response_to | 1.06228999 |
| 70 | MP0001881_abnormal_mammary_gland | 1.04872183 |
| 71 | MP0010030_abnormal_orbit_morphology | 1.04512574 |
| 72 | MP0002019_abnormal_tumor_incidence | 1.02248244 |
| 73 | MP0000516_abnormal_urinary_system | 1.01587040 |
| 74 | MP0005367_renal/urinary_system_phenotyp | 1.01587040 |
| 75 | MP0008877_abnormal_DNA_methylation | 1.01224125 |
| 76 | MP0005025_abnormal_response_to | 1.00671892 |
| 77 | MP0000613_abnormal_salivary_gland | 0.99665543 |
| 78 | MP0000566_synostosis | 0.96492102 |
| 79 | MP0001727_abnormal_embryo_implantation | 0.96156024 |
| 80 | MP0002234_abnormal_pharynx_morphology | 0.95799273 |
| 81 | MP0005379_endocrine/exocrine_gland_phen | 0.95138623 |
| 82 | MP0000015_abnormal_ear_pigmentation | 0.94920680 |
| 83 | MP0000685_abnormal_immune_system | 0.94068584 |
| 84 | MP0002095_abnormal_skin_pigmentation | 0.93688331 |
| 85 | MP0000049_abnormal_middle_ear | 0.93408533 |
| 86 | MP0008789_abnormal_olfactory_epithelium | 0.93126095 |
| 87 | MP0004742_abnormal_vestibular_system | 0.91062752 |
| 88 | MP0000689_abnormal_spleen_morphology | 0.91014166 |
| 89 | MP0002160_abnormal_reproductive_system | 0.89163419 |
| 90 | MP0002723_abnormal_immune_serum | 0.87531371 |
| 91 | MP0008995_early_reproductive_senescence | 0.86931183 |
| 92 | MP0005171_absent_coat_pigmentation | 0.85811482 |
| 93 | MP0000313_abnormal_cell_death | 0.85719167 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 0.84373450 |
| 95 | MP0000858_altered_metastatic_potential | 0.83278078 |
| 96 | MP0009764_decreased_sensitivity_to | 0.83238059 |
| 97 | MP0005451_abnormal_body_composition | 0.83203449 |
| 98 | MP0001853_heart_inflammation | 0.82874206 |
| 99 | MP0002693_abnormal_pancreas_physiology | 0.82260746 |
| 100 | MP0001542_abnormal_bone_strength | 0.80586919 |
| 101 | MP0008469_abnormal_protein_level | 0.80133559 |
| 102 | MP0002735_abnormal_chemical_nociception | 0.80117503 |
| 103 | MP0000762_abnormal_tongue_morphology | 0.78944430 |
| 104 | MP0001845_abnormal_inflammatory_respons | 0.78352793 |
| 105 | MP0002452_abnormal_antigen_presenting | 0.78128038 |
| 106 | MP0001929_abnormal_gametogenesis | 0.78127611 |
| 107 | MP0004043_abnormal_pH_regulation | 0.77067582 |
| 108 | MP0003123_paternal_imprinting | 0.76764581 |
| 109 | MP0005381_digestive/alimentary_phenotyp | 0.76702612 |
| 110 | MP0005389_reproductive_system_phenotype | 0.76458312 |
| 111 | MP0001800_abnormal_humoral_immune | 0.76043660 |
| 112 | MP0001819_abnormal_immune_cell | 0.75391397 |
| 113 | MP0002420_abnormal_adaptive_immunity | 0.75338584 |
| 114 | MP0001835_abnormal_antigen_presentation | 0.74635057 |
| 115 | MP0004019_abnormal_vitamin_homeostasis | 0.74508902 |
| 116 | MP0000653_abnormal_sex_gland | 0.73644966 |
| 117 | MP0003866_abnormal_defecation | 0.72773511 |
| 118 | MP0008260_abnormal_autophagy | 0.72186597 |
| 119 | MP0001663_abnormal_digestive_system | 0.71968873 |
| 120 | MP0002405_respiratory_system_inflammati | 0.71840245 |
| 121 | MP0002210_abnormal_sex_determination | 0.71412679 |
| 122 | MP0003436_decreased_susceptibility_to | 0.71325614 |
| 123 | MP0000350_abnormal_cell_proliferation | 0.70859490 |
| 124 | MP0001145_abnormal_male_reproductive | 0.70542093 |
| 125 | MP0000358_abnormal_cell_content/ | 0.70451047 |
| 126 | MP0005387_immune_system_phenotype | 0.70094170 |
| 127 | MP0001790_abnormal_immune_system | 0.70094170 |
| 128 | MP0003763_abnormal_thymus_physiology | 0.69985632 |
| 129 | MP0001485_abnormal_pinna_reflex | 0.69798963 |
| 130 | MP0001119_abnormal_female_reproductive | 0.69730312 |
| 131 | MP0000026_abnormal_inner_ear | 0.65391100 |
| 132 | MP0009250_abnormal_appendicular_skeleto | 0.65305719 |
| 133 | MP0001919_abnormal_reproductive_system | 0.65075551 |
| 134 | MP0002722_abnormal_immune_system | 0.64339663 |
| 135 | MP0002398_abnormal_bone_marrow | 0.64013765 |
| 136 | MP0002429_abnormal_blood_cell | 0.63588743 |
| 137 | MP0006082_CNS_inflammation | 0.63202050 |
| 138 | MP0000703_abnormal_thymus_morphology | 0.63020788 |
| 139 | MP0000716_abnormal_immune_system | 0.63017234 |
| 140 | MP0006072_abnormal_retinal_apoptosis | 0.62706385 |
| 141 | MP0000681_abnormal_thyroid_gland | 0.62337060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.40496925 |
| 2 | Reticulocytopenia (HP:0001896) | 5.85396324 |
| 3 | Acute necrotizing encephalopathy (HP:0006965) | 5.73256488 |
| 4 | Abnormal number of erythroid precursors (HP:0012131) | 5.62543176 |
| 5 | Mitochondrial inheritance (HP:0001427) | 5.30747582 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.03601265 |
| 7 | Macrocytic anemia (HP:0001972) | 5.00854327 |
| 8 | Increased hepatocellular lipid droplets (HP:0006565) | 4.71877082 |
| 9 | Progressive macrocephaly (HP:0004481) | 4.67395449 |
| 10 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.66753047 |
| 11 | Pallor (HP:0000980) | 4.53069839 |
| 12 | Hepatocellular necrosis (HP:0001404) | 4.48577604 |
| 13 | Acute encephalopathy (HP:0006846) | 4.40940029 |
| 14 | Increased CSF lactate (HP:0002490) | 4.37652846 |
| 15 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 4.36458195 |
| 16 | 3-Methylglutaconic aciduria (HP:0003535) | 4.18219715 |
| 17 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.06233514 |
| 18 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.06233514 |
| 19 | Renal Fanconi syndrome (HP:0001994) | 4.01333675 |
| 20 | Lipid accumulation in hepatocytes (HP:0006561) | 3.93739654 |
| 21 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.84534768 |
| 22 | Exertional dyspnea (HP:0002875) | 3.72592112 |
| 23 | Hepatic necrosis (HP:0002605) | 3.65636519 |
| 24 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.58883361 |
| 25 | Increased intramyocellular lipid droplets (HP:0012240) | 3.26065276 |
| 26 | Methylmalonic aciduria (HP:0012120) | 3.24209925 |
| 27 | Exercise intolerance (HP:0003546) | 3.19984960 |
| 28 | Abnormal hemoglobin (HP:0011902) | 3.18285974 |
| 29 | Increased serum lactate (HP:0002151) | 3.17694892 |
| 30 | Respiratory failure (HP:0002878) | 3.11671692 |
| 31 | Optic disc pallor (HP:0000543) | 3.09269893 |
| 32 | Methylmalonic acidemia (HP:0002912) | 3.05388954 |
| 33 | Leukodystrophy (HP:0002415) | 2.85214509 |
| 34 | Cerebral edema (HP:0002181) | 2.82135831 |
| 35 | Breast hypoplasia (HP:0003187) | 2.79409315 |
| 36 | Cerebral hypomyelination (HP:0006808) | 2.78002042 |
| 37 | Parakeratosis (HP:0001036) | 2.75963936 |
| 38 | Abnormal protein glycosylation (HP:0012346) | 2.75775100 |
| 39 | Abnormal glycosylation (HP:0012345) | 2.75775100 |
| 40 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.75775100 |
| 41 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.75775100 |
| 42 | Lethargy (HP:0001254) | 2.75321644 |
| 43 | Lactic acidosis (HP:0003128) | 2.64563168 |
| 44 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.59114646 |
| 45 | Respiratory difficulties (HP:0002880) | 2.57258392 |
| 46 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.55136049 |
| 47 | Abnormality of alanine metabolism (HP:0010916) | 2.55136049 |
| 48 | Hyperalaninemia (HP:0003348) | 2.55136049 |
| 49 | Reduced antithrombin III activity (HP:0001976) | 2.52926843 |
| 50 | Increased muscle lipid content (HP:0009058) | 2.48515814 |
| 51 | Concave nail (HP:0001598) | 2.46364301 |
| 52 | Abnormality of renal resorption (HP:0011038) | 2.43981885 |
| 53 | Microvesicular hepatic steatosis (HP:0001414) | 2.40935319 |
| 54 | IgG deficiency (HP:0004315) | 2.40500945 |
| 55 | Rough bone trabeculation (HP:0100670) | 2.34450771 |
| 56 | Triphalangeal thumb (HP:0001199) | 2.31742384 |
| 57 | Dicarboxylic aciduria (HP:0003215) | 2.29176744 |
| 58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.29176744 |
| 59 | Oral leukoplakia (HP:0002745) | 2.28684871 |
| 60 | Aplastic anemia (HP:0001915) | 2.27289486 |
| 61 | Glycosuria (HP:0003076) | 2.23752721 |
| 62 | Abnormality of urine glucose concentration (HP:0011016) | 2.23752721 |
| 63 | Abnormality of methionine metabolism (HP:0010901) | 2.22403699 |
| 64 | Abnormality of the anterior horn cell (HP:0006802) | 2.21562555 |
| 65 | Degeneration of anterior horn cells (HP:0002398) | 2.21562555 |
| 66 | Abnormality of glycolysis (HP:0004366) | 2.17281395 |
| 67 | Increased serum pyruvate (HP:0003542) | 2.17281395 |
| 68 | Absent thumb (HP:0009777) | 2.15292685 |
| 69 | Type I transferrin isoform profile (HP:0003642) | 2.15009231 |
| 70 | Amniotic constriction ring (HP:0009775) | 2.14427208 |
| 71 | Abnormality of placental membranes (HP:0011409) | 2.14427208 |
| 72 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.13206462 |
| 73 | Trismus (HP:0000211) | 2.10559467 |
| 74 | Progressive external ophthalmoplegia (HP:0000590) | 2.10526933 |
| 75 | Generalized aminoaciduria (HP:0002909) | 2.10083094 |
| 76 | B lymphocytopenia (HP:0010976) | 2.08204105 |
| 77 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.06052591 |
| 78 | Depressed nasal ridge (HP:0000457) | 2.02468616 |
| 79 | Abnormality of serum amino acid levels (HP:0003112) | 2.02321724 |
| 80 | Horseshoe kidney (HP:0000085) | 2.02254147 |
| 81 | Carpal bone hypoplasia (HP:0001498) | 2.00662969 |
| 82 | Asplenia (HP:0001746) | 2.00350785 |
| 83 | Cleft eyelid (HP:0000625) | 1.97813168 |
| 84 | Opisthotonus (HP:0002179) | 1.97634279 |
| 85 | Partial duplication of thumb phalanx (HP:0009944) | 1.97610420 |
| 86 | Abnormal trabecular bone morphology (HP:0100671) | 1.97099446 |
| 87 | Hyperphosphaturia (HP:0003109) | 1.96892708 |
| 88 | Abnormality of B cell number (HP:0010975) | 1.95983331 |
| 89 | Poor head control (HP:0002421) | 1.95100294 |
| 90 | Emotional lability (HP:0000712) | 1.93185026 |
| 91 | Progressive microcephaly (HP:0000253) | 1.91929012 |
| 92 | Hypoplasia of the radius (HP:0002984) | 1.91686753 |
| 93 | Partial duplication of the phalanx of hand (HP:0009999) | 1.89150272 |
| 94 | Birth length less than 3rd percentile (HP:0003561) | 1.85995804 |
| 95 | Premature graying of hair (HP:0002216) | 1.84926684 |
| 96 | CNS demyelination (HP:0007305) | 1.84067831 |
| 97 | Abnormality of vitamin B metabolism (HP:0004340) | 1.82778032 |
| 98 | Stenosis of the external auditory canal (HP:0000402) | 1.82728225 |
| 99 | Sensory axonal neuropathy (HP:0003390) | 1.80604935 |
| 100 | IgM deficiency (HP:0002850) | 1.80548239 |
| 101 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.78682127 |
| 102 | Obstructive lung disease (HP:0006536) | 1.78228251 |
| 103 | Chronic obstructive pulmonary disease (HP:0006510) | 1.78228251 |
| 104 | Abnormal pupillary function (HP:0007686) | 1.77155859 |
| 105 | Pancytopenia (HP:0001876) | 1.76309369 |
| 106 | Secondary amenorrhea (HP:0000869) | 1.76015483 |
| 107 | Neutropenia (HP:0001875) | 1.75634855 |
| 108 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.75472410 |
| 109 | Duplicated collecting system (HP:0000081) | 1.72690764 |
| 110 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.71850330 |
| 111 | Sparse eyelashes (HP:0000653) | 1.71409921 |
| 112 | Duplication of thumb phalanx (HP:0009942) | 1.70995423 |
| 113 | Hypoplasia of the pons (HP:0012110) | 1.70114622 |
| 114 | Absent radius (HP:0003974) | 1.69461134 |
| 115 | Congenital, generalized hypertrichosis (HP:0004540) | 1.69408351 |
| 116 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.68430107 |
| 117 | Abnormality of the preputium (HP:0100587) | 1.67998294 |
| 118 | Palpitations (HP:0001962) | 1.66966149 |
| 119 | Homocystinuria (HP:0002156) | 1.66829755 |
| 120 | Abnormality of homocysteine metabolism (HP:0010919) | 1.66829755 |
| 121 | Patellar aplasia (HP:0006443) | 1.66420589 |
| 122 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.65965595 |
| 123 | Abnormal urine phosphate concentration (HP:0012599) | 1.65864857 |
| 124 | Abnormality of T cell physiology (HP:0011840) | 1.65438425 |
| 125 | Pancreatic cysts (HP:0001737) | 1.64411170 |
| 126 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.63081692 |
| 127 | Supernumerary spleens (HP:0009799) | 1.61938836 |
| 128 | Renal tubular dysfunction (HP:0000124) | 1.61298721 |
| 129 | Hyperglycinemia (HP:0002154) | 1.60931173 |
| 130 | Abnormality of the axillary hair (HP:0100134) | 1.60892031 |
| 131 | Abnormality of secondary sexual hair (HP:0009888) | 1.60892031 |
| 132 | Metabolic acidosis (HP:0001942) | 1.59990899 |
| 133 | Vomiting (HP:0002013) | 1.59731498 |
| 134 | Hypergonadotropic hypogonadism (HP:0000815) | 1.59643160 |
| 135 | Abnormality of the pons (HP:0007361) | 1.59395274 |
| 136 | Aplasia involving forearm bones (HP:0009822) | 1.58748339 |
| 137 | Absent forearm bone (HP:0003953) | 1.58748339 |
| 138 | Microretrognathia (HP:0000308) | 1.57205567 |
| 139 | X-linked dominant inheritance (HP:0001423) | 1.55046586 |
| 140 | Nasolacrimal duct obstruction (HP:0000579) | 1.53954606 |
| 141 | Abnormality of reticulocytes (HP:0004312) | 1.53836603 |
| 142 | Testicular atrophy (HP:0000029) | 1.50876499 |
| 143 | Migraine (HP:0002076) | 1.49713665 |
| 144 | Blindness (HP:0000618) | 1.49008154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.33025198 |
| 2 | TLK1 | 4.85444624 |
| 3 | VRK2 | 4.74505056 |
| 4 | STK16 | 3.67506123 |
| 5 | BUB1 | 3.54316078 |
| 6 | EIF2AK1 | 2.95056324 |
| 7 | WEE1 | 2.50637586 |
| 8 | SRPK1 | 2.47076590 |
| 9 | NUAK1 | 2.45767202 |
| 10 | PBK | 2.45246694 |
| 11 | PIM2 | 2.43092896 |
| 12 | TESK2 | 2.29183974 |
| 13 | BCKDK | 2.21392937 |
| 14 | VRK1 | 2.18546023 |
| 15 | NME1 | 2.10533082 |
| 16 | CDK19 | 2.05306868 |
| 17 | CASK | 1.98401127 |
| 18 | ARAF | 1.87846506 |
| 19 | IRAK3 | 1.85697573 |
| 20 | MAP4K2 | 1.76506070 |
| 21 | BRAF | 1.74168123 |
| 22 | PLK4 | 1.60058068 |
| 23 | BLK | 1.54252818 |
| 24 | MST4 | 1.47974721 |
| 25 | IRAK4 | 1.43656255 |
| 26 | LIMK1 | 1.39875258 |
| 27 | NEK1 | 1.38047753 |
| 28 | MKNK2 | 1.37266784 |
| 29 | EIF2AK3 | 1.35107551 |
| 30 | MKNK1 | 1.29352920 |
| 31 | MAP3K12 | 1.28447591 |
| 32 | SCYL2 | 1.18901199 |
| 33 | TAF1 | 1.17937679 |
| 34 | GRK5 | 1.16644826 |
| 35 | MAP3K11 | 1.12339628 |
| 36 | ABL2 | 1.08848723 |
| 37 | GRK1 | 1.08502064 |
| 38 | STK39 | 1.08030424 |
| 39 | PDK2 | 1.07347972 |
| 40 | DYRK2 | 1.05783319 |
| 41 | AURKA | 1.05299729 |
| 42 | GRK7 | 1.01151026 |
| 43 | ZAK | 0.98421871 |
| 44 | IRAK1 | 0.97885101 |
| 45 | IRAK2 | 0.96555417 |
| 46 | DAPK1 | 0.95431875 |
| 47 | MAP2K2 | 0.95383956 |
| 48 | CDC7 | 0.94866669 |
| 49 | INSRR | 0.92796038 |
| 50 | DAPK3 | 0.92427261 |
| 51 | PLK1 | 0.91561597 |
| 52 | CDK7 | 0.91254855 |
| 53 | CSNK1G2 | 0.91033212 |
| 54 | EIF2AK2 | 0.89752593 |
| 55 | TAOK3 | 0.89167918 |
| 56 | PNCK | 0.88722555 |
| 57 | TESK1 | 0.88051231 |
| 58 | BMPR1B | 0.87642144 |
| 59 | ADRBK2 | 0.87497504 |
| 60 | FRK | 0.87057840 |
| 61 | DYRK3 | 0.86232413 |
| 62 | RPS6KA5 | 0.82106370 |
| 63 | TRIM28 | 0.80873363 |
| 64 | CLK1 | 0.79965242 |
| 65 | CSNK1A1L | 0.79361641 |
| 66 | KDR | 0.76963010 |
| 67 | MAPKAPK3 | 0.76591568 |
| 68 | PAK1 | 0.75565416 |
| 69 | IKBKB | 0.74690134 |
| 70 | BRSK2 | 0.74370542 |
| 71 | CDK8 | 0.72242405 |
| 72 | AURKB | 0.71702597 |
| 73 | CSNK2A2 | 0.70816317 |
| 74 | TSSK6 | 0.70609428 |
| 75 | CSNK2A1 | 0.70028097 |
| 76 | WNK3 | 0.69634767 |
| 77 | RPS6KB2 | 0.69621670 |
| 78 | MAPKAPK5 | 0.67316839 |
| 79 | PHKG2 | 0.67133881 |
| 80 | PHKG1 | 0.67133881 |
| 81 | CCNB1 | 0.64889251 |
| 82 | TXK | 0.63921153 |
| 83 | TTK | 0.63626856 |
| 84 | CSNK1G3 | 0.58716452 |
| 85 | PIM1 | 0.58687276 |
| 86 | UHMK1 | 0.57363143 |
| 87 | TNIK | 0.55959766 |
| 88 | ILK | 0.55645998 |
| 89 | PRKCI | 0.53949286 |
| 90 | TEC | 0.52530227 |
| 91 | YES1 | 0.51469424 |
| 92 | PKN1 | 0.50593686 |
| 93 | MAP3K8 | 0.50233358 |
| 94 | RPS6KA4 | 0.49190238 |
| 95 | ADRBK1 | 0.48830244 |
| 96 | LYN | 0.48515628 |
| 97 | EPHA2 | 0.48000201 |
| 98 | MYLK | 0.47191745 |
| 99 | MAP4K1 | 0.46884705 |
| 100 | OXSR1 | 0.46797078 |
| 101 | BCR | 0.46530470 |
| 102 | TBK1 | 0.45446137 |
| 103 | CHEK2 | 0.44567453 |
| 104 | FES | 0.43639830 |
| 105 | PAK4 | 0.42665718 |
| 106 | STK4 | 0.41766203 |
| 107 | CAMK2B | 0.41707032 |
| 108 | PLK3 | 0.41677564 |
| 109 | LRRK2 | 0.41601060 |
| 110 | FGR | 0.37761387 |
| 111 | ATR | 0.35019353 |
| 112 | MUSK | 0.34809205 |
| 113 | CSNK1A1 | 0.34563579 |
| 114 | ATM | 0.34524265 |
| 115 | IKBKE | 0.34293889 |
| 116 | MAP2K6 | 0.34109543 |
| 117 | BMPR2 | 0.33731102 |
| 118 | PRKCQ | 0.33296914 |
| 119 | BRSK1 | 0.32835217 |
| 120 | CSNK1G1 | 0.32753116 |
| 121 | CDK11A | 0.31985664 |
| 122 | MOS | 0.30004597 |
| 123 | SYK | 0.29916942 |
| 124 | CHEK1 | 0.29546246 |
| 125 | MAP2K7 | 0.29122954 |
| 126 | CAMK2D | 0.28666005 |
| 127 | CDK14 | 0.28573073 |
| 128 | CAMK2G | 0.28542291 |
| 129 | ITK | 0.28362272 |
| 130 | GRK6 | 0.27932049 |
| 131 | KIT | 0.27677741 |
| 132 | LCK | 0.26983915 |
| 133 | WNK4 | 0.26886929 |
| 134 | MAPK4 | 0.25108812 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 6.62860056 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.39736182 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 3.95635604 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.85005237 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.83674261 |
| 6 | Huntingtons disease_Homo sapiens_hsa05016 | 2.94111848 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.73993023 |
| 8 | Alzheimers disease_Homo sapiens_hsa05010 | 2.72558857 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.61782308 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.42636939 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.41389919 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.41106814 |
| 13 | Spliceosome_Homo sapiens_hsa03040 | 2.38346093 |
| 14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.34941732 |
| 15 | Mismatch repair_Homo sapiens_hsa03430 | 2.31845841 |
| 16 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.98280733 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.96703488 |
| 18 | Base excision repair_Homo sapiens_hsa03410 | 1.64262157 |
| 19 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.53878104 |
| 20 | Basal transcription factors_Homo sapiens_hsa03022 | 1.52709166 |
| 21 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.42808670 |
| 22 | RNA transport_Homo sapiens_hsa03013 | 1.42371769 |
| 23 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.37056346 |
| 24 | Sulfur relay system_Homo sapiens_hsa04122 | 1.35413147 |
| 25 | Purine metabolism_Homo sapiens_hsa00230 | 1.27952887 |
| 26 | RNA degradation_Homo sapiens_hsa03018 | 1.13486815 |
| 27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.03436036 |
| 28 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.99769995 |
| 29 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.95206257 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.95158183 |
| 31 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.93831391 |
| 32 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.89217559 |
| 33 | Cell cycle_Homo sapiens_hsa04110 | 0.87041039 |
| 34 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82476113 |
| 35 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.82331892 |
| 36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79741987 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.76829932 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.76692994 |
| 39 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.76217690 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74471889 |
| 41 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.71880014 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69935879 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.69746117 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68648288 |
| 45 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.67449049 |
| 46 | Allograft rejection_Homo sapiens_hsa05330 | 0.65494526 |
| 47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.65034819 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.62955239 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61700178 |
| 50 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61535142 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 0.61436590 |
| 52 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.60314261 |
| 53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.59887139 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59578245 |
| 55 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59395442 |
| 56 | Asthma_Homo sapiens_hsa05310 | 0.57642470 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.57176176 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55175129 |
| 59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54983501 |
| 60 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.53681884 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52668097 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.52329148 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51071203 |
| 64 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50930927 |
| 65 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49935143 |
| 66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48987180 |
| 67 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.48488591 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47363393 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.46058788 |
| 70 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.45621168 |
| 71 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.43624321 |
| 72 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42941741 |
| 73 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42124124 |
| 74 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.41433816 |
| 75 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.39721112 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.39698217 |
| 77 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38341888 |
| 78 | Alcoholism_Homo sapiens_hsa05034 | 0.37788938 |
| 79 | Phototransduction_Homo sapiens_hsa04744 | 0.37402699 |
| 80 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.36811015 |
| 81 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35597097 |
| 82 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.35075239 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.33726120 |
| 84 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.32627230 |
| 85 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.32398370 |
| 86 | Phagosome_Homo sapiens_hsa04145 | 0.32261734 |
| 87 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.32124811 |
| 88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31653209 |
| 89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.30007536 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.29558875 |
| 91 | Retinol metabolism_Homo sapiens_hsa00830 | 0.28447255 |
| 92 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.27576555 |
| 93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.27349866 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27325135 |
| 95 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.27260147 |
| 96 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.26976706 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26898214 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.25488337 |
| 99 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.22521651 |
| 100 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.22425385 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20961688 |
| 102 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.20466014 |
| 103 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.19483121 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | 0.18397219 |
| 105 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.18252852 |
| 106 | Pertussis_Homo sapiens_hsa05133 | 0.18047582 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.17889346 |
| 108 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.16304910 |
| 109 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.16298461 |
| 110 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.16099475 |
| 111 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.14576824 |
| 112 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.14137115 |
| 113 | Measles_Homo sapiens_hsa05162 | 0.12363205 |
| 114 | Apoptosis_Homo sapiens_hsa04210 | 0.11698003 |
| 115 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.11611382 |
| 116 | Shigellosis_Homo sapiens_hsa05131 | 0.11266911 |
| 117 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.11171849 |
| 118 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.11119545 |
| 119 | Legionellosis_Homo sapiens_hsa05134 | 0.10383029 |
| 120 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.10034021 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.09034119 |
| 122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.08983154 |
| 123 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.06912470 |
| 124 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.06295605 |
| 125 | Salmonella infection_Homo sapiens_hsa05132 | 0.05561627 |
| 126 | Leishmaniasis_Homo sapiens_hsa05140 | 0.05445940 |
| 127 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.05441918 |
| 128 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.05155687 |

